Nonalcoholic Steatohepatitis, Peroxisome Proliferator-Activated Receptors and Our Good Glitazar: Proof of the Pudding is in the Eating.

Anand, Anil C; Acharya, Subrata K

Anand, Anil C; Acharya, Subrata K.

Afiliación

Anand AC; Department of Gastroenterology & Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, 751024 Odisha, India.
Acharya SK; KIIT University, Bhubaneswar, 751024 Odisha, India.

J Clin Exp Hepatol ; 12(2): 263-267, 2022.

Article en En | MEDLINE | ID: mdl-35535098

Palabras clave

AE, adverse event; CAP, controlled attenuation parameter; CDSCO, Central Drugs Standard Control Organisation; LSM, liver stiffness measurement; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PPAR, peroxisome proliferatoractivated receptors; TG, triglyceride

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Exp Hepatol Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google